OTCMKTS:OPTHF Optimi Health (OPTHF) Stock Forecast, Price & News $0.13 0.00 (0.00%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$0.13▼$0.1450-Day Range$0.13▼$0.1652-Week Range$0.13▼$0.29Volume5,249 shsAverage Volume16,332 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesShort InterestProfileChartCompetitorsHeadlinesShort Interest About Optimi Health (OTCMKTS:OPTHF) StockOptimi Health Corp. develops an integrated functional mushroom brand that focuses on the health and wellness food markets in Canada. The company also focuses on the cultivation, extraction, processing, and distribution of strains of functional mushroom. It offers a range of fungi varieties, which include Lions Mane, Reishi, Turkey Tail, Chaga, and Cordyceps. The company was formerly known as 1251418 BC Ltd. and changed its name to Optimi Health Corp. in August 2020. Optimi Health Corp. was incorporated in 2020 and is headquartered in Vancouver, Canada.Read More OPTHF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OPTHF Stock News HeadlinesSeptember 15, 2023 | proactiveinvestors.comPsychedelics CEOs heartened by MDMA for PTSD study results as stocks maintain momentumSeptember 14, 2023 | finance.yahoo.comOptimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical TrialOctober 1, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.September 8, 2023 | benzinga.comOptimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private FinancingSeptember 7, 2023 | finance.yahoo.comOptimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access ProgramSeptember 5, 2023 | finance.yahoo.comOptimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt FinancingAugust 10, 2023 | finance.yahoo.comOptimi Health Announces CAD $3,000,000 Senior Debt FinancingAugust 1, 2023 | finance.yahoo.comOptimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional PatentOctober 1, 2023 | Altimetry (Ad)WARNING: Seven millionaires to trigger sudden market panic?The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.July 27, 2023 | finance.yahoo.comOptimi Health Announces Receipt of Purported Termination NoticeJuly 12, 2023 | finance.yahoo.comOPTHF - Optimi Health Corp.June 20, 2023 | benzinga.comMDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian UniversityJune 15, 2023 | finance.yahoo.comOptimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPSMay 17, 2023 | finance.yahoo.comOptimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical MarketMay 11, 2023 | msn.comOptimi Health Boosts Psilocybin Production With New Health Canada License And Supply DealMay 10, 2023 | finance.yahoo.comOptimi Health Granted Natural Health Product Site Licence By Health CanadaMay 10, 2023 | finance.yahoo.comOptimi Health Granted Natural Health Product Site Licence By Health CanadaMay 4, 2023 | finance.yahoo.comOptimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and DevelopmentApril 5, 2023 | markets.businessinsider.comWhat To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging IndustryMarch 2, 2023 | benzinga.comLatest Psychedelics Deals: Optimi Supplies Australia, Awakn Partners Licensing In CaliforniaMarch 1, 2023 | finance.yahoo.comOptimi Health Enters Australian Medical MDMA And Psilocybin Market With Mind Medicine Australia Distribution AgreementFebruary 28, 2023 | benzinga.comOptimi Health Stock (OTC:OPTHF), Quotes and News SummaryFebruary 24, 2023 | finance.yahoo.comIIROC Trading Halt - OPTI.WTFebruary 9, 2023 | benzinga.comHow Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find OutFebruary 7, 2023 | finance.yahoo.comOptimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy TherapistsFebruary 6, 2023 | msn.comMDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch EvaluationsFebruary 6, 2023 | finance.yahoo.comOptimi Health Completes First Production of Novel MDMA Drug Candidate OPTI-MHCLSee More Headlines Receive OPTHF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Optimi Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Farm Products Sub-IndustryN/A SectorConsumer Defensive Current SymbolOTCMKTS:OPTHF CUSIPN/A CIKN/A Webwww.optimihealth.ca PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. John James Wilson (Age 33)Co-Founder & Non-Exec. Chairman Comp: $73.12kMr. William J. Ciprick (Age 46)Chief Exec. Officer Comp: $258.51kMr. Bryan Edward Safarik (Age 38)Co-Founder, COO & Director Comp: $55.4kMr. Jacob Safarik (Age 36)Co-Founder, CFO & Director Comp: $58.35kMr. Dane Stevens (Age 34)Co-Founder, Chief Marketing Officer & Director Comp: $56.87kMr. Justin D. KirklandChief Science Officer and Member of PIR Medical & Clinical Advisory BoardLaura ChowDirector of Products & SalesMs. Ann LittleHR Mang.Ms. Leah Hodges (Age 39)Corp. Sec. More ExecutivesKey CompetitorsAgriFORCE Growing SystemsNASDAQ:AGRIWAstral FoodsOTC:ALFDFAtlantic Sapphire ASAOTC:AASZFAustevoll Seafood ASAOTCMKTS:ASTVFCalifornia OrchardOTC:CAOXView All Competitors OPTHF Stock - Frequently Asked Questions How have OPTHF shares performed in 2023? Optimi Health's stock was trading at $0.1747 at the beginning of the year. Since then, OPTHF shares have decreased by 24.0% and is now trading at $0.1328. View the best growth stocks for 2023 here. Are investors shorting Optimi Health? Optimi Health saw a increase in short interest in the month of September. As of September 15th, there was short interest totaling 43,000 shares, an increase of 190.5% from the August 31st total of 14,800 shares. Based on an average trading volume of 36,000 shares, the days-to-cover ratio is presently 1.2 days. View Optimi Health's Short Interest. What is Optimi Health's stock symbol? Optimi Health trades on the OTCMKTS under the ticker symbol "OPTHF." How do I buy shares of Optimi Health? Shares of OPTHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Optimi Health's stock price today? One share of OPTHF stock can currently be purchased for approximately $0.13. This page (OTCMKTS:OPTHF) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Optimi Health Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.